BioSpace News Archive

Plus Therapeutics, Inc. issued the following Letter to Shareholders from Dr. Marc Hedrick, President and Chief Executive Officer..

Brooks Automation, Inc. announced that company management will participate in the 22nd Annual Needham Growth Conference at the Lotte New York Palace hotel.

Nephros, Inc. announced preliminary financial results for the fiscal year ended December 31, 2019.

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it has entered into a collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd., or Kyorin, a wholly owned subsidiary of Kyorin Holdings, Inc.,

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the company will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco.

Golden Leaf Holdings Ltd., a pioneering cannabis solutions company and dispensary operator built around the recognized brands of Chalice Farms, is pleased to announce that it has sold its two Canadian subsidiaries, Medical Marihuana Group Corporation and Medical Marijuana Group Consulting Ltd., to Sensi Brands Inc., a global cannabis consumer packaged goods company.

HealthLynked Corp., a nationwide healthcare network focused on care management of its members and a provider of technologies that connects doctors, patients and medical data, announced that it will host a Year-End Shareholder Update Webcast that will be held on Thursday, January 9th at 12:00pm ET.

Carisma Therapeutics Inc. announced the expansion of its leadership team with Debora Barton, M.D., as Chief Medical Officer, and Tom Wilton, as Chief Business Officer.

Cigna’s Health Coaching, Case Management Specialists and Expanded Behavioral Health Offerings improve clinical outcomes and drive affordability for customers, employers and partners

Daiichi Sankyo Company, Limited announced that ENHERTU®, a HER2 directed antibody drug conjugate, is now available by prescription in the U.S.